JB Chemicals acquisition loan open in syndication
JB Chemicals & Pharmaceuticals’ $206m loan is open in general syndication, with the proceeds going to support private equity firm KKR’s acquisition of a majority stake in the company.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: